Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children under 18 years old who have had kidney stones and/or calcium deposits in the kidneys (nephrocalcinosis)
- Adults over 18 who have had kidney stones and/or calcium deposits in the kidneys, AND at least one of the following: a family history of kidney stones, calcium deposits, or unexplained kidney failure; slow or stunted growth; bone disease related to metabolism; unusual types of kidney stones or crystals in the urine; protein in the urine; reduced kidney function; abnormal levels of magnesium, phosphate, or calcium in the blood; high levels of oxalate; or cysts on the kidneys
- People where a doctor strongly suspects they may have a genetic (inherited) kidney stone disease or a condition affecting how the body processes calcium
- People who were previously enrolled in a related study called "Genetic Characterization and Genotype/Phenotype Correlations in Primary Hyperoxaluria" (Rare Kidney Stone Consortium protocol 6406) and already gave consent for their samples to be used in genetic research
- People who were previously enrolled in a related study called "Screening for Dent Disease Mutations in Patients with Proteinuria or Hypercalciuria and Calcium Urolithiasis" (Rare Kidney Stone Consortium protocol 6403) and already gave consent for their samples to be used in genetic research
- A family member of anyone who meets any of the criteria listed above
Who may not be able to join:
- People who have had kidney stones but do not meet the specific criteria that suggest a genetic cause for their condition
- Anyone who is unwilling or unable to give their consent (or assent, for younger participants) to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Sas, DO, Mayo Clinic
Phone: 800-270-4637
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
symptomatic onset of monogenic stone disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.